Clinical trials recruiting in Neuss, Germany

Phase breakdown

Conditions recruiting in Neuss, Germany

Recruiting trials in Neuss, Germany

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
  NCT06868277 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
  NCT07578584 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female)
• A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
  NCT07270731 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female)
• A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity
  NCT07721597 · Phase: Early Phase 1 · Ages: 18 Years to 60 Years · Sex: Male
• A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
  NCT07230691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
  NCT07665879 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
  NCT06945406 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
  NCT07702890 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
  NCT04673955 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
  NCT05362760 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female
• Comparison Study of Insulin GZR4 With Insulin Degludec
  NCT07146347 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation
  NCT06313944 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female)
• Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
  NCT07535307 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
  NCT06272136 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
  NCT06494540 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female)
• PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study
  NCT07621003 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
  NCT05008809 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
  NCT06712355 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
  NCT06712316 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
  NCT06726720 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Neuss, Germany?

21 recruiting trials have at least one study site in Neuss, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.